Date Filer Title Filing Type Shares Traded Price Total Held
Feb 15, 2023
Chief Medical Officer
Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 560,000 -- 560,000
Feb 15, 2023
Chief Operating Officer
Chief Operating Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 560,000 -- 560,000
Dec 01, 2021
Director, President and CEO
Director, President and CEO Form 4 Other acquisition or disposition -- -- 585,191
May 12, 2021
Director, President and CEO
Director, President and CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 290,000 -- 585,191
Aug 23, 2018
Ten Percent Owner
Ten Percent Owner Form 4 Conversion of derivative security 591,184 -- 591,184
Apr 01, 2021
Director, President and CEO
Director, President and CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 775,000 -- 775,000
May 12, 2023
Director, President and CEO
Director, President and CEO Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 50,141 $0.66 791,474
May 16, 2023
Director, President and CEO
Director, President and CEO Form 4 Open market or private purchase of non-derivative or derivative security 15,000 $0.64 806,474
Feb 15, 2023
Director, President and CEO
Director, President and CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 300,000 -- 841,615
Aug 23, 2018
Ten Percent Owner
Ten Percent Owner Form 4 Conversion of derivative security 337,694 $4.59 929,878

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.